Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07140640
PHASE4

Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.

Sponsor: Aswan University

View on ClinicalTrials.gov

Summary

Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.

Key Details

Gender

FEMALE

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

333

Start Date

2025-09-15

Completion Date

2026-03-30

Last Updated

2025-08-25

Healthy Volunteers

Yes

Interventions

DRUG

Hyperbaric Bupivacaine HCl 0.5% 12.5 mg

1- Standard dose group: receiving the typical dose of hyperbaric bupivacaine (12.5 mg hyperbaric bupivacaine + 25 mcg fentanyl).

DRUG

Hyperbaric Bupivacaine HCl 0.5% 10 mg

2- Reduced dose group: receiving a20% reduced dose of hyperbaric bupivacaine (10 mg hyperbaric bupivacaine + 25 mcg fentanyl).

Locations (1)

Aswan university

Aswān, Aswan Governorate, Egypt